TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: Evidence from a meta-analysis
2016 ◽
Vol 5
(6)
◽
pp. 705-713
◽
Keyword(s):
Keyword(s):
2017 ◽
Keyword(s):
2012 ◽
Vol 13
(11)
◽
pp. 875-883
◽
Keyword(s):
Keyword(s):